- Investing Ideas
- /
- German Pharmaceuticals & Biotech Undiscovered Growth Opportunities
German Pharmaceuticals & Biotech Undiscovered Growth Opportunities
UPDATED May 18, 2022
The market has not yet priced in the high-growth prospects for these companies, featuring low PEG ratio (less than 0.5), high future growth outlook and good value on the Snowflake.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| UQ1uniQure | €13.16 | -1.8% | -50.6% | €660.1m | €49.95 | PS2x | E22.5% | n/a | ||
| UQ1uniQure | €13.50 | -4.5% | -50.0% | €660.1m | €51.22 | PS2x | E22.5% | n/a | ||
| 84CClene | €2.04 | -13.6% | -72.2% | €139.8m | €13.85 | PS8.4x | E72.5% | n/a | ||
| X0M1XOMA | €16.40 | -1.8% | -33.9% | €203.0m | €57.68 | PS16.9x | E58.1% | n/a | ||
| VB0Viva Biotech Holdings | €0.26 | 4.0% | -64.6% | €4.3b | n/a | PS13x | E36.0% | 0% |
Page 1 of 1